ARCHANA CHOPRA: Open Payments
NPI 1033266044 · CHAMPAIGN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 13 payments from 4 companies in 2025. Trend: 2023 $384 · 2024 $557 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $250 |
| Alkermes, Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: INGREZZA, ARISTADA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across IL — which companies pay providers there.
